614 related articles for article (PubMed ID: 33432113)
21. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
22. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.
Trulsson F; Akimov V; Robu M; van Overbeek N; Berrocal DAP; Shah RG; Cox J; Shah GM; Blagoev B; Vertegaal ACO
Nat Commun; 2022 May; 13(1):2736. PubMed ID: 35585066
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitination: Friend and foe in cancer.
Mansour MA
Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.
Voutsadakis IA
Tumour Biol; 2012 Aug; 33(4):897-910. PubMed ID: 22399444
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Zhao CX; Zeng CM; Wang K; He QJ; Yang B; Zhou FF; Zhu H
Acta Pharmacol Sin; 2021 Feb; 42(2):179-188. PubMed ID: 32601365
[TBL] [Abstract][Full Text] [Related]
26. The role of allostery in the ubiquitin-proteasome system.
Liu J; Nussinov R
Crit Rev Biochem Mol Biol; 2013; 48(2):89-97. PubMed ID: 23234564
[TBL] [Abstract][Full Text] [Related]
27. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
29. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
30. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
31. Linear ubiquitination at a glance.
Spit M; Rieser E; Walczak H
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30659056
[TBL] [Abstract][Full Text] [Related]
32. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
Soucy TA; Smith PG; Rolfe M
Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
[TBL] [Abstract][Full Text] [Related]
33. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
[TBL] [Abstract][Full Text] [Related]
34. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
Nguyen HC; Wang W; Xiong Y
Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
[TBL] [Abstract][Full Text] [Related]
35. Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
Liess AKL; Kucerova A; Schweimer K; Schlesinger D; Dybkov O; Urlaub H; Mansfeld J; Lorenz S
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082289
[TBL] [Abstract][Full Text] [Related]
36. Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.
Vittal V; Stewart MD; Brzovic PS; Klevit RE
J Biol Chem; 2015 Aug; 290(35):21244-51. PubMed ID: 26187467
[TBL] [Abstract][Full Text] [Related]
37. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
Guharoy M; Bhowmick P; Tompa P
J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
[TBL] [Abstract][Full Text] [Related]
38. Human disorders of ubiquitination and proteasomal degradation.
Jiang YH; Beaudet AL
Curr Opin Pediatr; 2004 Aug; 16(4):419-26. PubMed ID: 15273504
[TBL] [Abstract][Full Text] [Related]
39. Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs.
Evans PC
Expert Rev Mol Med; 2005 Jun; 7(12):1-19. PubMed ID: 15967057
[TBL] [Abstract][Full Text] [Related]
40. Current and future directions of USP7 interactome in cancer study.
Park HB; Baek KH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
